Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anton Camacho

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Lancet. Infectious Diseases|August 23, 2024
Effectiveness of rVSV-ZEBOV vaccination during the 2018-20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative studySophie Meakin, Justus Nsio, Anton Camacho, et al.
Plos Currents|March 5, 2015
Temporal Changes in Ebola Transmission in Sierra Leone and Implications for Control Requirements: a Real-time Modelling StudyAnton Camacho, Adam Kucharski, Yvonne Aki-Sawyerr, et al.
Elife|November 4, 2015
Ebola virus disease in the Democratic Republic of the Congo, 1976-2014Alicia Rosello, Mathias Mossoko, Stefan Flasche, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 12, 2017
The impact of control strategies and behavioural changes on the elimination of Ebola from Lofa County, LiberiaSebastian Funk, Iza Ciglenecki, Amanda Tiffany, et al.
PLOS Global Public Health|May 2, 2025
Using an analogue-digital hybrid clinical data management platform during a two-dose preventive Ebola virus vaccine trial in Goma, the Democratic Republic of the CongoHannah E Brindle, Darius Tetsa-Tata, Tansy Edwards, et al.
BMJ Open|March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the CongoDeborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
The Lancet. Global Health|January 10, 2026
Health-economic impacts of age-targeted and sex-targeted Lassa fever vaccination in endemic regions of Nigeria, Guinea, Liberia, and Sierra Leone: a modelling studyDavid R M Smith, Mary Chriselda Antony Oliver, Katherine M Holohan, et al.
Epidemics|June 15, 2014
OutbreakTools: a new platform for disease outbreak analysis using the R softwareThibaut Jombart, David M Aanensen, Marc Baguelin, et al.
The Lancet. Global Health|May 8, 2018
Cholera epidemic in Yemen, 2016-18: an analysis of surveillance dataAnton Camacho, Malika Bouhenia, Reema Alyusfi, et al.
The Lancet. Infectious Diseases|October 17, 2017
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety reportPierre-Stéphane Gsell, Anton Camacho, Adam J Kucharski, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Lancet. Infectious Diseases|August 23, 2024
Effectiveness of rVSV-ZEBOV vaccination during the 2018-20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative studySophie Meakin, Justus Nsio, Anton Camacho, et al.
Plos Currents|March 5, 2015
Temporal Changes in Ebola Transmission in Sierra Leone and Implications for Control Requirements: a Real-time Modelling StudyAnton Camacho, Adam Kucharski, Yvonne Aki-Sawyerr, et al.
Elife|November 4, 2015
Ebola virus disease in the Democratic Republic of the Congo, 1976-2014Alicia Rosello, Mathias Mossoko, Stefan Flasche, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 12, 2017
The impact of control strategies and behavioural changes on the elimination of Ebola from Lofa County, LiberiaSebastian Funk, Iza Ciglenecki, Amanda Tiffany, et al.
PLOS Global Public Health|May 2, 2025
Using an analogue-digital hybrid clinical data management platform during a two-dose preventive Ebola virus vaccine trial in Goma, the Democratic Republic of the CongoHannah E Brindle, Darius Tetsa-Tata, Tansy Edwards, et al.
BMJ Open|March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the CongoDeborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
The Lancet. Global Health|January 10, 2026
Health-economic impacts of age-targeted and sex-targeted Lassa fever vaccination in endemic regions of Nigeria, Guinea, Liberia, and Sierra Leone: a modelling studyDavid R M Smith, Mary Chriselda Antony Oliver, Katherine M Holohan, et al.
Epidemics|June 15, 2014
OutbreakTools: a new platform for disease outbreak analysis using the R softwareThibaut Jombart, David M Aanensen, Marc Baguelin, et al.
The Lancet. Global Health|May 8, 2018
Cholera epidemic in Yemen, 2016-18: an analysis of surveillance dataAnton Camacho, Malika Bouhenia, Reema Alyusfi, et al.
The Lancet. Infectious Diseases|October 17, 2017
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety reportPierre-Stéphane Gsell, Anton Camacho, Adam J Kucharski, et al.
Pageof 4